XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 107.90%3.12B | 27.73%3.77B | -0.61%1.5B | -10.66%2.95B | -2.45%1.51B | 6.51%3.3B | 3.58%1.55B | 3.24%3.1B | -3.35%1.49B | 29.95%3B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 8.51%-316.8M | -234.50%-806.66M | -172.71%-346.26M | -67.55%-241.15M | -554.02%-126.97M | -202.21%-143.93M | 53.69%-19.41M | 61.36%-47.63M | -158.93%-41.92M | ---123.26M |
Interest expense - adjustment | -83.92%4.94M | ---- | 7.27%30.74M | ---- | 5.69%28.66M | ---- | 5,938.75%27.11M | 1,237.40%1.65M | 1,022.50%449K | --123K |
Investment loss (gain) | -101.11%-84.65M | -413.42%-115.17M | -1,062.71%-42.09M | 75.01%-22.43M | 95.11%-3.62M | -24.87%-89.76M | -214.27%-74.1M | -177.84%-71.88M | -34.11%-23.58M | -46.45%-25.87M |
Attributable subsidiary (profit) loss | ---- | -84.68%2.12M | 173.58%2.12M | --13.86M | --776K | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | 2,569.35%41.38M | 132.56%24.03M | -13.55%1.55M | 787.63%10.33M | 138.11%1.79M | -24.46%1.16M | -88.98%753K | -77.94%1.54M | 396.73%6.83M | 172.15%6.99M |
-Impairment of property, plant and equipment (reversal) | --27.67M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | 258.13%6.77M | -48.27%1.65M | -1,471.15%-4.28M | 816.43%3.18M | -57.44%312K | -81.24%347K | -88.56%733K | -76.84%1.85M | --6.41M | --7.99M |
-Impairment of trade receivables (reversal) | 19.13%6.94M | 212.96%22.38M | 293.52%5.83M | 775.40%7.15M | 7,305.00%1.48M | 364.40%817K | -95.25%20K | 69.19%-309K | -69.38%421K | -139.07%-1M |
Revaluation surplus: | -105.36%-55.78M | -123.12%-150.79M | -258.87%-27.16M | 49.95%-67.58M | 116.78%17.1M | -54.93%-135.03M | -98.78%-101.86M | -277.08%-87.16M | -41.42%-51.24M | 27.24%-23.11M |
-Other fair value changes | -105.36%-55.78M | -123.12%-150.79M | -258.87%-27.16M | 49.95%-67.58M | 116.78%17.1M | -54.93%-135.03M | -98.78%-101.86M | -277.08%-87.16M | -41.42%-51.24M | 27.24%-23.11M |
Asset sale loss (gain): | 109.12%499K | 15.21%-9.53M | -149.04%-5.47M | -185.72%-11.24M | -358.46%-2.2M | -10,189.74%-3.94M | -588.78%-479K | -96.98%39K | -75.38%98K | 77.58%1.29M |
-Loss (gain) from sale of subsidiary company | ---- | ---10.78M | ---4.06M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | 135.52%499K | 81.30%-2.1M | 36.02%-1.41M | -185.72%-11.24M | -358.46%-2.2M | -10,189.74%-3.94M | -588.78%-479K | -96.98%39K | -75.38%98K | 77.58%1.29M |
-Loss (gain) from selling other assets | ---- | --3.35M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | 17.27%216.53M | 6.33%365.91M | 16.91%184.64M | 23.79%344.13M | 16.97%157.93M | 19.17%278M | 23.73%135.02M | 15.74%233.27M | 9.79%109.12M | 26.69%201.55M |
-Amortization of intangible assets | 34.33%6.89M | 21.82%10.76M | 34.08%5.13M | 41.21%8.83M | 22.83%3.83M | 24.03%6.26M | 77.49%3.12M | -57.94%5.04M | -72.99%1.76M | 56.96%11.99M |
-Other depreciation and amortization | 0.00%-236K | 0.00%-472K | 0.00%-236K | 0.00%-472K | 0.00%-236K | ---472K | ---236K | ---- | ---- | ---- |
Financial expense | ---- | 14.68%66.68M | ---- | 10.08%58.14M | ---- | --52.82M | ---- | ---- | ---- | ---- |
Special items | -21.62%67.59M | -9.59%306.08M | 68.43%86.23M | 417.08%338.54M | 21.63%51.19M | -4.55%65.47M | 146.41%42.09M | --68.59M | --17.08M | ---- |
Operating profit before the change of operating capital | 116.15%2.99B | 2.31%3.45B | -15.28%1.38B | 1.39%3.37B | 4.99%1.63B | 4.01%3.32B | 3.03%1.56B | 5.20%3.2B | -4.19%1.51B | 25.45%3.04B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 79.43%-30.49M | -216.38%-129.54M | -69.76%-148.22M | 63.36%-40.94M | -181.89%-87.31M | -198.22%-111.75M | -237.57%-30.97M | 98.46%113.77M | -60.83%22.51M | 273.11%57.33M |
Accounts receivable (increase)decrease | 9.51%268.89M | 277.86%341.76M | -61.71%245.55M | 116.46%90.45M | 1,304.52%641.26M | 37.66%-549.35M | 60.65%-53.24M | -320.16%-881.19M | 25.68%-135.28M | 187.92%400.25M |
Accounts payable increase (decrease) | -27.08%84.15M | 125.54%85.96M | 162.44%115.39M | -179.31%-336.5M | -199.44%-184.81M | -10.84%424.31M | -122.80%-61.72M | 26.23%475.91M | -16.26%270.75M | -16.90%377.01M |
prepayments (increase)decrease | -27.39%-134.56M | -150.57%-54.32M | -72.91%-105.62M | -19.71%-21.68M | 30.50%-61.09M | 77.32%-18.11M | -142.15%-87.89M | -1,168.22%-79.86M | -163.29%-36.3M | -58.61%-6.3M |
Special items for working capital changes | -381.46%-20.31M | 361.81%13.37M | 180.58%7.22M | 101.67%2.9M | -199.32%-8.96M | -211.77%-173.49M | -45.91%9.02M | 3,633.02%155.22M | 146.40%16.67M | 179.95%4.16M |
Cash from business operations | 110.85%3.16B | 20.91%3.71B | -22.47%1.5B | 5.83%3.07B | 45.18%1.93B | -2.82%2.9B | -19.25%1.33B | -23.00%2.98B | -6.76%1.65B | 62.76%3.87B |
Other taxs | -35.44%-477.2M | -81.95%-589.58M | -121.55%-352.33M | -1.44%-324.03M | 35.67%-159.03M | 45.87%-319.44M | 13.96%-247.23M | -9.00%-590.1M | 0.91%-287.33M | -76.82%-541.4M |
Net cash from operations | 134.03%2.68B | 13.69%3.12B | -35.39%1.15B | 6.37%2.74B | 63.62%1.77B | 7.81%2.58B | -20.37%1.08B | -28.21%2.39B | -7.91%1.36B | 60.68%3.33B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 102.34%316.08M | 387.19%541.62M | 92.95%156.21M | -25.97%111.17M | 210.71%80.96M | 137.43%150.17M | -20.45%26.06M | -41.18%63.25M | --32.76M | --107.53M |
Decrease in deposits (increase) | -23.40%2.73B | 83.51%-987.39M | 162.65%3.57B | 12.81%-5.99B | -26.47%-5.69B | -548.35%-6.87B | -418.88%-4.5B | 153.62%1.53B | 88.68%-867.72M | ---2.86B |
Sale of fixed assets | 694.50%18.92M | -48.04%10.96M | -32.85%2.38M | -61.48%21.1M | -8.58%3.55M | 578.61%54.77M | 2,168.42%3.88M | -26.93%8.07M | -70.16%171K | 33.86%11.05M |
Purchase of fixed assets | -9.94%-101.85M | 19.51%-219.6M | 50.17%-92.64M | 40.70%-272.82M | 26.32%-185.91M | 67.78%-460.03M | 16.77%-252.33M | -140.96%-1.43B | -5.52%-303.19M | -55.35%-592.48M |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | --247K | ---- | ---- | ---- | ---- |
Purchase of intangible assets | -141.01%-245.9M | -652.16%-142.93M | -511.68%-102.03M | -23.33%-19M | -4,546.24%-16.68M | -32.77%-15.41M | 91.25%-359K | -141.07%-11.61M | -1.01%-4.1M | 81.37%-4.81M |
Sale of subsidiaries | ---- | --249.72M | --166.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | 69.46%150.25M | -128.02%-168.73M | 201.78%88.67M | -91.87%602.14M | 102.41%29.38M | 4,603.62%7.4B | -1,684.13%-1.22B | 155.75%157.38M | 88.55%77.05M | 27.40%61.54M |
Cash on investment | 79.66%-67.42M | 558.61%1.79B | ---331.41M | 84.54%-390.38M | ---- | ---2.52B | ---- | ---- | ---- | 45.91%-761M |
Other items in the investment business | 82.01%-434.22M | ---- | -866.94%-2.41B | ---- | -95.06%314.69M | ---- | 227.64%6.37B | -5.07%-3.2B | -235.00%-4.99B | -924.29%-3.04B |
Net cash from investment operations | 127.37%2.37B | 118.10%1.07B | 119.05%1.04B | -162.71%-5.94B | -1,398.43%-5.47B | 21.40%-2.26B | 106.96%421.15M | 59.38%-2.87B | 35.62%-6.05B | -409.50%-7.08B |
Net cash before financing | 130.86%5.05B | 231.20%4.19B | 159.22%2.19B | -1,104.66%-3.19B | -345.44%-3.69B | 165.73%317.91M | 132.08%1.51B | 87.09%-483.65M | 40.79%-4.69B | -648.06%-3.75B |
Cash flow from financing activities | ||||||||||
New borrowing | --500M | --900M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Refund | ---500M | ---900M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuing shares | ---- | ---- | ---- | ---- | ---- | -99.52%15.11M | -99.52%15.11M | -66.73%3.17B | -63.13%3.17B | --9.53B |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | --3.85B | ---- | ---- | ---- | ---- |
Interest paid - financing | ---3.21M | ---5.77M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid - financing | ---- | 8.44%-652.08M | ---- | -86.99%-712.18M | ---- | 90.93%-380.87M | 97.08%-64.34M | -180.00%-4.2B | -266.67%-2.2B | ---1.5B |
Issuance expenses and redemption of securities expenses | ---4.18B | -13.24%-114.87M | ---- | -74.97%-101.43M | ---- | ---57.97M | ---- | ---- | ---- | ---- |
Other items of the financing business | 98.78%-507K | 189.03%37.99M | 12.45%-41.47M | --13.14M | -101.23%-47.36M | ---- | --3.85B | ---- | ---- | ---- |
Net cash from financing operations | -8,216.31%-4.2B | 7.88%-753.7M | 7.97%-50.46M | -123.94%-818.14M | -101.44%-54.83M | 429.92%3.42B | 291.84%3.8B | -112.96%-1.04B | -87.84%968.67M | --7.99B |
Effect of rate | 45.79%-39.23M | -201.65%-122.36M | 72.36%-72.38M | 48.84%-40.57M | -190.66%-261.84M | 89.60%-79.29M | 477.74%288.79M | -672.23%-762.27M | 238.71%49.99M | 793.79%133.21M |
Net Cash | -60.01%854.92M | 185.66%3.44B | 157.01%2.14B | -207.43%-4.01B | -170.73%-3.75B | 345.82%3.73B | 242.38%5.3B | -135.77%-1.52B | -9,147.33%-3.72B | 521.35%4.25B |
Begining period cash | 124.31%5.98B | -60.32%2.67B | -60.32%2.67B | 119.33%6.72B | 119.33%6.72B | -42.69%3.06B | -42.69%3.06B | 453.97%5.34B | 453.97%5.34B | 262.11%964.83M |
Cash at the end | 43.64%6.8B | 124.31%5.98B | 74.75%4.73B | -60.32%2.67B | -68.71%2.71B | 119.33%6.72B | 417.56%8.65B | -42.69%3.06B | 63.79%1.67B | 453.97%5.34B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.